REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Xu Lam Biotechnology Pte. Ltd. (Singapore)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Wholesale Trade Agents and Brokers
Full name: Xu Lam Biotechnology Pte. Ltd. Profile Updated: December 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Primary Business Activity: research and experimental development on biotechnology (except medical and veterinary science); Secondary Business Activity: wholesale on a fee or commission basis

Legal Address
438B Alexandra Road, #05-08/09, Alexandra Technopark, Singapore 119968
Singapore; Singapore; Postal Code: 119968

Contact Details: Purchase the Xu Lam Biotechnology Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Xu Lam Biotechnology Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Xu Lam Biotechnology Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Xu Lam Biotechnology Pte. Ltd. report to view the information.
Incorporation Date:
June 06, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
55%
Purchase this report to view the information.
25%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Subsidiaries
Ganko Singapore Pte. Ltd.
78.5%
Company Performance
Financial values in the chart are available after Xu Lam Biotechnology Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-31.38%▼
Total operating revenue
-31.38%▼
Net Profit (Loss) for the Period
-75.37%▼
Total Assets
-72.48%▼
Total Equity
-64.37%▼
Net Profit Margin
-47.86%▼
Return on Equity (ROE)
2.45%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo